Physician

Ismail Loai Bekdash, M.D.

According to 2025 Medicare claims, Ismail Bekdash, M.D. (NPI: 1386814044) practices interventional cardiology in the Fargo, ND-MN market, with the plurality of this provider's patient population coming from Cass, ND. This provider's primary affiliated billing organization is SANFORD MEDICAL CENTER FARGO (NPI: 1184917924; TIN: 450226909) and primary practice location at 58104-7927. Bekdash is affiliated with the Caravan Collaborative Pathways (ACO ID: A4604), Caravan Health ACO 50 LLC (ACO ID: A5160), Collaborative ACO 30, LLC (ACO ID: A5483), Essentia Health ACO, Inc. (ACO ID: A5617), and CoreHealth Alliance LLC (ACO ID: A5645), participating under the MSSP model.

Bekdash's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 975 traditional Medicare patients, billed 2,991 HCPCS/CPT codes, and received $257,928 in Medicare payments. The top billing code was 93458 (Insertion of tube in left lower heart chamber and coronary artery for diagnosis with review by radiologist). Part D data shows 993 prescription claims across 282 beneficiaries totaling $164,854 in drug costs, led by Eliquis (Apixaban). Open Payments data shows 1 records totaling $23. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has risen steadily, from $180,490 to $257,928. Concurrently, Part D prescription costs have moved up and down with repeated peaks and valleys, starting at $112,171 and ending at $164,854. For DME billing, this provider has fewer than 5 years of reported data, so a reliable trend cannot be assigned.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Year	Patients	Clm Lines	Payment
2015	1,853	3,748	$180,490
2016	1,838	3,801	$142,720
2017	399	731	$104,023
2018	511	1,268	$151,091
2019	655	2,238	$222,740
2020	809	2,458	$239,626
2021	719	2,412	$243,371
2022	616	2,095	$204,677
2023	916	2,836	$245,999
2024	975	2,991	$257,928

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Year	Patients	Claims	Drug Cost
2015	277	2,009	$112,171
2016	301	2,055	$139,789
2017	271	1,040	$97,097
2018	195	752	$58,705
2019	234	813	$71,630
2020	352	1,201	$127,825
2021	342	1,131	$133,335
2022	280	1,021	$112,891
2023	282	1,043	$147,114
2024	282	993	$164,854

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

No connected DME records

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

Code	Description	Patients	Clm Lines	Total Payment
93458	Insertion of tube in left lower heart chamber and coronary artery for diagnosis with review by radiologist	151	152	$169
99214	Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more	242	257	$67
93306	Ultrasound of heart with color-depicted blood flow, rate, direction and valve function	342	410	$51
99152	Use of a drug to induce depression of consciousness by physician performing a procedure (5 years or older), initial 15 minutes	211	220	$9
93010	Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report only	443	667	$6

Top 5 Part D drugs in 2024

By total drug costs.

Drug	Generic	Claims	Total Day Supply	Total Drug Cost
Eliquis	Apixaban	88	4,339	$81,648
Xarelto	Rivaroxaban	44	1,950	$35,462
Repatha Sureclick	Evolocumab	20	896	$16,734
Brilinta	Ticagrelor	13	901	$12,776
Enoxaparin Sodium	Enoxaparin Sodium	41	200	$3,515

Top 5 DME services in 2024

No connected or detailed DME service-level records for 2024.

Open Payments Summary in 2024

Category	Definition	Records	Total Reported Amount	Top Related Entity
General Payments	Reported payment or transfer-of-value amount.	1	$23	Abbott Laboratories
Research Payments	Reported research-related payment or transfer-of-value amount.	0	$0	N/R
Ownership / Investment Interests	Reported value of ownership or investment interests.	0	$0	N/R

Explore More Providers

FAQ

What Medicare data is available for Ismail Loai Bekdash, M.D.?

Tedicare shows public-source Medicare data for Ismail Loai Bekdash, M.D. (NPI 1386814044), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Ismail Loai Bekdash, M.D. have ACO affiliation data?

Ismail Loai Bekdash, M.D. is shown with ACO affiliation data for Caravan Collaborative Pathways (MSSP, ACO ID A4604), Caravan Health ACO 50 LLC (MSSP, ACO ID A5160), Collaborative ACO 30, LLC (MSSP, ACO ID A5483), Essentia Health ACO, Inc. (MSSP, ACO ID A5617), and CoreHealth Alliance LLC (MSSP, ACO ID A5645).

What billing organization is linked to Ismail Loai Bekdash, M.D.?

Ismail Loai Bekdash, M.D. is linked to SANFORD MEDICAL CENTER FARGO (billing NPI 1184917924) in the available physician profile data.

Does Ismail Loai Bekdash, M.D. have Open Payments data?

Ismail Loai Bekdash, M.D. has 1 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.